Proteome Sciences plc (LON:PRM – Get Free Report) hit a new 52-week low during mid-day trading on Thursday . The company traded as low as GBX 1.20 and last traded at GBX 1.60, with a volume of 725 shares changing hands. The stock had previously closed at GBX 1.40.
Proteome Sciences Trading Up 14.3%
The company has a current ratio of 0.13, a quick ratio of 0.37 and a debt-to-equity ratio of -165.46. The firm has a market capitalization of £5.61 million, a price-to-earnings ratio of -1.54 and a beta of 0.16. The firm’s 50-day moving average is GBX 1.72 and its 200 day moving average is GBX 1.65.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
See Also
- Five stocks we like better than Proteome Sciences
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
- Chewy’s Sell-Off Puts Its Recurring Revenue Story Back on Trial for Investors
- Insider Sales Eclipse $450M Across 3 AI Winners, With NVIDIA Leading the Pack
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
